Remdesivir as a broad-spectrum antiviral drug against COVID-19
Y.-N. Hong, J. Xu, G.B.K. Sasa, K.-X. Zhou, X.-F. Ding Zhejiang Sci-Tech University, Zhejiang, HangZhou, China. bdd114@163.com
OBJECTIVE: List the clinical data of the role of remdesivir in COVID-19, and try to make an objective evaluation and analyze its feasibility.
MATERIALS AND METHODS: The keywords of “remdesivir”, “COVID-19” and “SARS-CoV-2” were systematically searched in PubMed and Web of Science. After removing the repetitions, we summarize articles, letters, and comments on remdesivir in the treatment of COVID-19.
RESULTS: In this review, we summarize clinical case of using remdesivir in the treatment of COVID-19, analyzed the final treatment results, and judged whether the drug was effective for the treatment of COVID-19. Also, attention was paid to the side effects of the drug.
CONCLUSIONS: According to the clinical results, it was found that remdesivir was effective in the treatment of COVID-19. The drug has side effects, but the symptoms were mild and disappeared immediately after discontinuation of medication.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Y.-N. Hong, J. Xu, G.B.K. Sasa, K.-X. Zhou, X.-F. Ding
Remdesivir as a broad-spectrum antiviral drug against COVID-19
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 1
Pages: 541-548
DOI: 10.26355/eurrev_202101_24426